ロード中...
B Cell Therapy for Multiple Sclerosis: Entering an Era
Monoclonal antibodies that target CD20 expressing B cells represent an important new treatment option for patients with multiple sclerosis (MS). B cell depleting therapy is highly effective against relapsing forms of the disease, and is also the first treatment approach proven to protect against dis...
保存先:
| 出版年: | Ann Neurol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5876115/ https://ncbi.nlm.nih.gov/pubmed/29244240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25119 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|